IL22 and bacterial infectious disease: IL-36R signaling promotes IL-23/IL-22/antimicrobial peptide and IL-6/IL-22/antimicrobial peptide-mediated inhibition of intestinal pathogenic bacterial infection by integrating innate and adaptive immune responses (Figure 2) [99].